Zacks Investment Research
08 Jul 2026, 14:01 UTC · 15w ago
Impact · against what's priced in
Pfizer is experiencing a downward trend characterized by declining earnings projections for the current and next fiscal years. The stock is significantly underperforming its industry peers, signaling a lack of immediate catalysts to reverse the current trajectory.
No priced-in read yet
What the story claims
4 claims · scored −1 bearish … +1 bullish
Pfizer's consensus earnings estimate for the current quarter is $0.68 per share, a year-over-year decrease of 12.8%.
More negative than 84% of claims this week
Pfizer's consensus earnings estimate for the current fiscal year is $2.98, representing a 7.5% decrease from the prior year.
Continue reading
5 related stories
The company faces a negative outlook with current quarter earnings expected to drop 12.8% year-over-year and a projected 7.5% decrease for the full fiscal year.
Read from the article alone
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More negative than 76% of claims this week
Pfizer's earnings estimate for the next fiscal year is $2.86, a projected 4.2% decrease from the previous year.
More negative than 68% of claims this week
Pfizer's shares have returned -6.3% over the past month, underperforming both the Zacks S&P 500 composite (1.6%) and the Large Cap Pharmaceuticals industry (9.1%).
More negative than 61% of claims this week
Which stocks this story touches
More negative than 71% of ticker scores this week
The stock has underperformed the S&P 500 and its industry, with negative year-over-year earnings projections.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
—
No price for PFE right now — the quote feed didn't answer.
PFE chart →
